ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XGN vs TLSI // ENTERPRISE SCALE & MARKET CAP

Exagen Inc. (NASDAQ) VS. TriSalus Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: XGN 4 — TLSI 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TLSI
market-cap
$210.8M
market-cap
$237.7M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XGN VS. TLSI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XGN TLSI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 58.30% 84.60% -26.30 TLSI /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.77% -7.96% +1.19 XGN /fcf-yield <GO>
Operating Margin -21.10% -59.70% +38.60 XGN /operating-margins <GO>
Net Profit Margin -30.00% -60.00% +30.00 XGN /net-margins <GO>
Revenue Growth (YoY) 19.70% 53.40% -33.70 TLSI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.9 44.9 +15.00 XGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $210.8M $237.7M -$26.9M TLSI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XGN REV TLSI REV XGN GROSS % TLSI GROSS % XGN FCF TLSI FCF
FY 2025 $66.6M $45.2M 58.3% 84.6% -$14.3M -$18.9M
FY 2024 $55.6M $29.4M 59.5% 86.1% -$13.8M -$41.2M
FY 2023 $52.5M $18.5M — — -$14.5M -$50.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XGN // BETA —
TLSI // BETA —